Therapeutic potential of tertiary lymphoid structures in breast cancer (Review)
Open Access
- 24 April 2026
- journal article
- review article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 33 (6) , 1-14
Abstract
Tertiary lymphoid structures (TLS) are organized immune aggregates within the tumor microenvironment that are associated with improved prognosis and immunotherapy response in breast cancer, yet their functional duality and therapeutic potential require further clarification. The present review comprehensively summarizes current knowledge on TLS in breast cancer, focusing on their molecular mechanisms of formation and maturation, multifaceted functions in anti‑tumor immunity, established prognostic importance and emerging strategies for therapeutic targeting. The present study highlights that mature and functional TLS are key mediators of adaptive anti‑tumor immunity, whereas immature TLS may have opposing effects. Their presence and characteristics hold strong prognostic value and can predict response to immune checkpoint inhibitors. Consequently, therapeutic strategies aimed at inducing or enhancing TLS represent a promising direction for breast cancer immunotherapy. However, further research is needed to elucidate the precise regulatory networks and translate TLS‑focused strategies into clinical practice.Keywords
This publication has 66 references indexed in Scilit:
- Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancerCancer Cell, 2025
- Co-expression network and survival analysis of breast cancer inflammation and immune system hallmark genesComputational Biology and Chemistry, 2024
- Triple‐negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor buddingCancer, 2024
- Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancerCancer Cell, 2024
- Tertiary lymphoid structures and B cells: An intratumoral immunity cycleImmunity, 2023
- Analysis of the Correlation and Prognostic Significance of Tertiary Lymphoid Structures in Breast Cancer: A Radiomics‐Clinical Integration ApproachJournal of Magnetic Resonance Imaging, 2023
- CCL19+ dendritic cells potentiate clinical benefit of anti-PD-(L)1 immunotherapy in triple-negative breast cancerMed, 2023
- Tumor-Infiltrating Lymphocytes (TIL), Tertiary Lymphoid Structures (TLS), and Expression of PD-1, TIM-3, LAG-3 on TIL in Invasive and In Situ Ductal Breast Carcinomas and Their Relationship with Prognostic FactorsClinical Breast Cancer, 2022
- The prognostic significance of peritumoral tertiary lymphoid structures in breast cancerCancer Immunology, Immunotherapy, 2019
- FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancerEBioMedicine, 2019